IMPACT OF RIFAXIMIN ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME

被引：0
|
作者：
Cash, Brooks D.
Heimanson, Zeev
Chang, Lin
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1599
引用
收藏
页码：S913 / S913
页数：1
相关论文
共 50 条
  • [21] Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
    Lacy, Brian E.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 7 - 17
  • [22] The intestinal microbiome of diarrhea-predominant irritable bowel syndrome
    Carroll, I. M.
    Ringel-Kulka, T.
    Siddle, J. P.
    Ringel, Y.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 : 13 - 13
  • [23] Role of Diet in Diarrhea-predominant Irritable Bowel Syndrome
    Singh, Prashant
    Nee, Judy
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (01) : 25 - 29
  • [24] Targeted therapies for diarrhea-predominant irritable bowel syndrome
    Olden, Kevin W.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 69 - 100
  • [25] Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Ozdener, Ayse Elif
    Rivkin, Anastasia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2827 - 2840
  • [26] Patients Sith Diarrhea-Predominant Irritable Bowel Syndrome Have Lower Disease-Specific Quality of Life Than Constipation-Predominant Irritable Bowel Syndrome
    Singh, Prashant
    Staller, Kyle
    Barshop, Kenneth
    Dai, Elaine
    Newman, Jennifer
    Yoon, Sonia
    Castel, Shahar
    Kuo, Braden
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S536 - S537
  • [27] Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
    Li, Pingping
    Zheng, Jimin
    Bai, Yun
    Wang, Dingxin
    Cui, Zijin
    Li, Yueqin
    Zhang, Jian
    Wang, Yuzhen
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 : 14 - 21
  • [28] Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome
    Sayuk, Gregory S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2021, 50 (03) : 611 - 637
  • [29] Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
    Mangel, Allen W.
    Chaturvedi, Pravin
    DIGESTION, 2008, 78 (04) : 180 - 186
  • [30] Impact of irritable bowel syndrome on health-related quality of life (HRQOL).
    Mayer, EA
    Hays, RD
    Kilbourne, A
    Mayer, EA
    Yei, JY
    GASTROENTEROLOGY, 1999, 116 (04) : A1038 - A1038
12345